TY - JOUR
T1 - Protective effects of Acanthopanax koreanum Kakai extract against carbon tetrachloride-induced liver injury in Sprague-Dawley rats
AU - Yang, Yoon Kyoung
AU - Wang, Lin
AU - Kwon, Oran
PY - 2014/4
Y1 - 2014/4
N2 - Purpose: This study was conducted in order to investigate the protective effects of ethanolic extract of Acanthopanax ko-reanum Nakai (AE) against carbon tetrachloride (CCl4)-induced liver injury in rats. Methods: Male Sprague-Dawley rats were randomly divided into four groups in order to receive the following experimental diets with intraperitoneal injection of CCl4 (2.0 mL/kg body weight, 20% solution 0.65 mL) for eight weeks (n = 8 per group): CCl4 control (CON), CCl4 + AE 1% (AE1), CCl4 + AE 3% (AE3), or CCl4 + acanthoic acid 0.037%, which is equivalent to AE 3% (AA). Results: Highest serum ALT activity and albumin level were observed in the CCL4 control group, but showed a significant decrease by either AE or AA supplementation in a dose-dependent manner (p = 0.0063 and 0.0076, respectively). Both hemotoxylin and eosin staining and Masson's staining indicated remarkable prevention of CCl4-induced liver damage in the AE3 group. TNFá and IL-6 production were significantly lowered in the AE treated groups, but not in the AA group (p = 0.0016 and p = 0.0002, respectively). The effects of AE3 were greater than those of AA for inflammation and liver toxicity biomarkers. Con-clusion: Taken together, the results suggested that ethanolic extract of Acanthopanax koreanum Nakai provided hepa-toprotective effects, leading to the reduction of inflammatory response. In addition, the effect of AE was superior to that of single compound AA.
AB - Purpose: This study was conducted in order to investigate the protective effects of ethanolic extract of Acanthopanax ko-reanum Nakai (AE) against carbon tetrachloride (CCl4)-induced liver injury in rats. Methods: Male Sprague-Dawley rats were randomly divided into four groups in order to receive the following experimental diets with intraperitoneal injection of CCl4 (2.0 mL/kg body weight, 20% solution 0.65 mL) for eight weeks (n = 8 per group): CCl4 control (CON), CCl4 + AE 1% (AE1), CCl4 + AE 3% (AE3), or CCl4 + acanthoic acid 0.037%, which is equivalent to AE 3% (AA). Results: Highest serum ALT activity and albumin level were observed in the CCL4 control group, but showed a significant decrease by either AE or AA supplementation in a dose-dependent manner (p = 0.0063 and 0.0076, respectively). Both hemotoxylin and eosin staining and Masson's staining indicated remarkable prevention of CCl4-induced liver damage in the AE3 group. TNFá and IL-6 production were significantly lowered in the AE treated groups, but not in the AA group (p = 0.0016 and p = 0.0002, respectively). The effects of AE3 were greater than those of AA for inflammation and liver toxicity biomarkers. Con-clusion: Taken together, the results suggested that ethanolic extract of Acanthopanax koreanum Nakai provided hepa-toprotective effects, leading to the reduction of inflammatory response. In addition, the effect of AE was superior to that of single compound AA.
KW - Acanthopanax koreanum Nakai
KW - Hepatoprotective effects
KW - Interleukin-6
KW - Tumor necrosis factor-alpha
UR - http://www.scopus.com/inward/record.url?scp=84901001081&partnerID=8YFLogxK
U2 - 10.4163/jnh.2014.47.2.106
DO - 10.4163/jnh.2014.47.2.106
M3 - Article
AN - SCOPUS:84901001081
SN - 2288-3886
VL - 47
SP - 106
EP - 112
JO - Journal of Nutrition and Health
JF - Journal of Nutrition and Health
IS - 2
ER -